Abstract
Sixty-eight patients with a clinical diagnosis of cutaneous candidiasis confirmed by a potassium hydroxide (KOH) examination and culture studies were treated with haloprogin cream or nystatin ointment in a double-blind study. Each of the drugs was applied for 13 consecutive days. The results of clinical observations, KOH examination, and culture studies showed that there was no significant difference in the efficacy of these two drugs in the treatment of cutaneous candidal infections. The cure rate for both products exceeded 80%. The efficacy of haloprogin in the treatment of dermatophytoses and candidiasis shows that it has a broad spectrum of antimicrobial activity, with no known toxicity or reported important adverse reactions when used in the approved dosages.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
